Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.94)
# 1,370
Out of 5,163 analysts
17
Total ratings
75%
Success rate
25.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $480 → $390 | $73.25 | +432.42% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.86 | +5,722.08% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $33.28 | +20.19% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $7.34 | +2,216.08% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $8.81 | +127.01% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $23.26 | +114.96% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $178.55 | -19.35% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $480 → $390
Current: $73.25
Upside: +432.42%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.86
Upside: +5,722.08%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $33.28
Upside: +20.19%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $7.34
Upside: +2,216.08%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $8.81
Upside: +127.01%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $23.26
Upside: +114.96%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $178.55
Upside: -19.35%